abstract |
The invention concerns leucotriene B4 derivatives of the formula (I) in which: n = 1-10, R1 is the CH2OH, COOR4, CONHR5 or CONR6R7 residue, A is a cis/trans or trans/trans -CH=CH-CH=CH- group or a tetramethylene group, B is an alkylene group with up to 10 C-atoms, D is a direct link, oxygen, sulphur, a -C=C- group or a -CH=CR8- group, B and D together form a direct link, R2 is a hydrogen atom or an acid residue of an organic acid with 1-15 C-atoms, R3 is a hydrogen atom, an alkyl residue (which may be substituted ) with 1-10 C-atoms, a cycloalkyl residue with 3-10 C-atoms, an aryl residue (which may be substituted ) with 6-10 C-atoms or a 5- or 6-membered heterocyclic residue plus, if R4 is a hydrogen atom, their salts with physiologically compatiblel bases and their cyclodextrinclathrates, as well as a method for their preparation and their pharmaceutical use. |